8-K: ModivCare Amends Credit Agreement, Secures Increased Leverage Flexibility

ModivCare Inc. has amended its credit agreement to increase its maximum permitted leverage ratio through March 2026, providing enhanced financial flexibility.

Summary

• ModivCare Inc. has entered into an amendment to its credit agreement, increasing the maximum permitted Total Net Leverage Ratio.
• The amendment provides covenant relief through the fiscal quarter ending March 31, 2026.
• The maximum permitted Total Net Leverage Ratio will be 5.50 to 1.00 for the fiscal quarters ending March 31, 2024 through June 30, 2024.
• The ratio will be 5.25 to 1.00 for the fiscal quarters ending September 30, 2024 through December 31, 2024.
• The ratio will be 5.00 to 1.00 for the fiscal quarters ending March 31, 2025 through September 30, 2025.
• The ratio will be 4.75 to 1.00 for the fiscal quarters ending December 31, 2025 through March 31, 2026.
• ModivCare may elect to end the Covenant Relief Period earlier, subject to certain conditions, which would revert the leverage ratio to pre-amendment levels.
• During the Covenant Relief Period, the interest rate margin will increase by 50 basis points.
• A minimum liquidity of $100 million is required, tested at the end of each fiscal quarter during the Covenant Relief Period.
• The minimum Interest Coverage Ratio is reduced to 2.75 to 1.00 from 3.00 to 1.00 during the Covenant Relief Period.

Sentiment

Score: 7

Explanation: The document indicates a proactive approach to managing financial obligations, which is generally positive. However, the increased interest rate and minimum liquidity requirements are slightly negative.

Positives

• The increased leverage ratio provides ModivCare with greater financial flexibility.
• The company has the option to end the Covenant Relief Period early if conditions allow.

Negatives

• The interest rate margin will increase by 50 basis points during the Covenant Relief Period.
• A minimum liquidity of $100 million is required during the Covenant Relief Period.

Risks

• The company is subject to increased interest rate costs during the Covenant Relief Period.
• The company must maintain a minimum liquidity of $100 million during the Covenant Relief Period.

Future Outlook

The company may elect to end the Covenant Relief Period prior to March 31, 2026, subject to certain conditions, upon which the maximum permitted Total Net Leverage Ratio will revert to the level established prior to the Second Amendment.

Industry Context

This amendment reflects a trend of companies seeking increased financial flexibility in response to changing market conditions. It is common for companies to renegotiate credit agreements to adjust to their current financial performance and future needs.

Comparison to Industry Standards

• Many companies in the healthcare services sector have similar credit agreements with leverage ratios that fluctuate based on performance and market conditions.
• The specific leverage ratios and interest rate adjustments are tailored to ModivCare's financial situation and are not directly comparable to all other companies.
• The minimum liquidity requirement of $100 million is a common feature in credit agreements to ensure operational stability.

Stakeholder Impact

• Shareholders may view the increased leverage flexibility as a positive development.
• Creditors will benefit from the increased interest rate margin during the Covenant Relief Period.
• Employees may not be directly impacted by this amendment.

Next Steps

• ModivCare will operate under the amended credit agreement terms.
• The company will monitor its leverage ratio and liquidity to ensure compliance.
• ModivCare may elect to end the Covenant Relief Period early if conditions allow.

Key Dates

Keywords

credit agreement, leverage ratio, covenant relief, interest rate, liquidity, ModivCare, financial flexibility, Interest Coverage Ratio